StockData
AIM ImmunoTech Inc. logo

AIM ImmunoTech Inc. (AIM) income statement

AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.14+0.01 (+3.82%)

Close on Nov 17, 2026Market cap $4.14MP/E –Yield –

AIM ImmunoTech Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
-11724.2%
Net margin
-15021.1%
Return on equity, FY2025
251.4%

Financial strength

Current ratio
2.11
Debt to equity
–
Debt to assets
–
Cash to current liabilities
200.2%

Valuation

P/E ratio
–
Price to sales
43.58
Price to book
0.53
Dividend yield
–

See a number that looks wrong?